超選擇性肝動脈栓塞治療多囊肝的長期療效觀察.pdf

《超選擇性肝動脈栓塞治療多囊肝的長期療效觀察.pdf》由會員上傳分享，免費在線閱讀，更多相關內(nèi)容在行業(yè)資料-天天文庫。

1、·134·中華臨床醫(yī)師雜志f電子~)2013年12月第7卷第24靚ChinCliniciansfE1ectronicEdition)．December15．2013．v0l_7．No．24臨床論著超選擇性肝動脈栓塞治療多囊肝的長期療效觀察常中飛袁凱王茂強劉鳳永段峰閻潔羽【摘要】目的評價用超選擇性肝動脈栓塞術(TAE)治療多囊肝(PLD)的長期療效和安全性。方法對23例有嚴重癥狀的PLD患者進行超選擇性肝動脈栓塞術。患者女l9例，男4例，年齡36．O～68．0歲，平均(49．3±3．4)歲。所有患者在TAE前后行上腹部CT平掃+增強掃描：TAE后第3個月、第6個月及此后每間隔半年復

2、查CT。結果23例患者共行27次介入治療，手術技術成功率為100％，中位隨訪時間為19個月(3~58個月)，2例無效，可供評價療效者21例，有效率為91．2％。術前患者平均腹圍為(1O5．7±8．1)cm，術后患者平均腹圍為(95．2±6．7)cm，術前術后平均腹圍具有統(tǒng)計學差異(P

3、肝Thesafetyandlong-termeficiencyoftranscathetersuper-selectivehepaticarterialembolizationfortreatmentwithpolycysticfiverdiseaseCHANGZhong-fei；YUANKai,NGMao-qiang,LIUFeng-yong,DUANFeng,YANJie-yu．*DepartmentofOncology,BeijingShijingshanHospital,ShijingshanTeachingHospitalofCapitalMedicalUniversi

4、ty,Beijing100043，ChinaCorrespondingauthor：WANGMao-qiang,Email：wangmq@vip．sina．com[Abstract]ObjectiveToevaluatethesafetyandlong-termeficacyoftranscathetersuper—selectivehepaticarterialembolization(TAE)forpatientswithpolycysticliverdiseasefPLD)．MethodsAtotalof23patientswithsymptomaticPLDwereenr

5、olled．epatientsconsistedofnineteenwomenandfourmen[aged36．O一68．0years，meanage(49．3±3．4)years]．Allpatientsunderwentcontrastenhancedcomputedtomography(CT)scanoftheliverbeforeTAEandatevery3monthsforthefirsthalfyearafterTAE，andat6-monthlyintervalsthereafter．ResultsFollow-upwasperformedatamedianof1

6、9months(range3-58months)．23casesweretreatedbyintervention27times．AllprocedureswereSuccessfu1withoutseriouscomplications．TAEfailedtobenefitin2patients，buttherewerenocomplaintsofworseningofthesymptoms．a(chǎn)vailablefor21patientsevaluableforeficacy,efectiverateof91．2％．Theaveragepreoperativeabdominalc

7、ircumferencewas(105．7±8．1)cm．theaveragepostoperativeabdominalcircumferencewas(95．2±6．7)cm．Aftertreatmentaverageabdominalcircumferencereduction10．1cm(3．0-21．0cm)，statisticallysignificant(P<0．001)．Aftertreatmentaverageabdominalcircumferencebega